Inicio>>Signaling Pathways>> Neuroscience>> Histamine Receptor>>Mebhydrolin napadisylate (Mebhydroline 1,5-naphthalenedisulfonate salt)

Mebhydrolin napadisylate (Mebhydroline 1,5-naphthalenedisulfonate salt)

Catalog No.GC31848

El napadisilato de mebhidrolina (sal de 1,5-naftalenodisulfonato de mebhidrolina) es un antagonista especÍfico del receptor de histamina H1.

Products are for research use only. Not for human use. We do not sell to patients.

Mebhydrolin napadisylate (Mebhydroline 1,5-naphthalenedisulfonate salt) Chemical Structure

Cas No.: 6153-33-9

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
50,00 $
Disponible
100mg
46,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Mebhydrolin napadisylate is a specific histamine H1 receptor antagonist.

Mebhydrolin is a specific histamine H1-receptor antagonist with minimal sedative properties and comparing it with the effects of chlorpromazine, the archetypical phenothiazine[1]. Mebhydrolin exerts an antihistaminic effect over the period of the ethanol interaction study[2].

[1]. O'Neill PA, et al. Chlorpromazine-a specific effect on breathlessness? Br J Clin Pharmacol. 1985 Jun;19(6):793-7. [2]. Franks HM, et al. Interaction between ethanol and antihistamines: 3. Mebhydrolin. Med J Aust. 1981 Oct 31;2(9):477-9.

Reseñas

Review for Mebhydrolin napadisylate (Mebhydroline 1,5-naphthalenedisulfonate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Mebhydrolin napadisylate (Mebhydroline 1,5-naphthalenedisulfonate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.